Literature DB >> 26709840

Nasal Wipes for Influenza A Virus Detection and Isolation from Swine.

Jacqueline M Nolting1, Christine M Szablewski1, Jody L Edwards1, Sarah W Nelson1, Andrew S Bowman2.   

Abstract

Surveillance for influenza A viruses in swine is critical to human and animal health because influenza A virus rapidly evolves in swine populations and new strains are continually emerging. Swine are able to be infected by diverse lineages of influenza A virus making them important hosts for the emergence and maintenance of novel influenza A virus strains. Sampling pigs in diverse settings such as commercial swine farms, agricultural fairs, and live animal markets is important to provide a comprehensive view of currently circulating IAV strains. The current gold-standard ante-mortem sampling technique (i.e. collection of nasal swabs) is labor intensive because it requires physical restraint of the pigs. Nasal wipes involve rubbing a piece of fabric across the snout of the pig with minimal to no restraint of the animal. The nasal wipe procedure is simple to perform and does not require personnel with professional veterinary or animal handling training. While slightly less sensitive than nasal swabs, virus detection and isolation rates are adequate to make nasal wipes a viable alternative for sampling individual pigs when low stress sampling methods are required. The proceeding protocol outlines the steps needed to collect a viable nasal wipe from an individual pig.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26709840      PMCID: PMC4692777          DOI: 10.3791/53313

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  32 in total

1.  Genetic characterization of an H1N2 influenza virus isolated from a pig in Indiana.

Authors:  A I Karasin; C W Olsen; G A Anderson
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Simultaneous infection of pigs and people with triple-reassortant swine influenza virus H1N1 at a U.S. county fair.

Authors:  M L Killian; S L Swenson; A L Vincent; J G Landgraf; B Shu; S Lindstrom; X Xu; A Klimov; Y Zhang; A S Bowman
Journal:  Zoonoses Public Health       Date:  2012-07-09       Impact factor: 2.702

3.  Reassortment of pandemic H1N1/2009 influenza A virus in swine.

Authors:  D Vijaykrishna; L L M Poon; H C Zhu; S K Ma; O T W Li; C L Cheung; G J D Smith; J S M Peiris; Y Guan
Journal:  Science       Date:  2010-06-18       Impact factor: 47.728

4.  The Inability to Screen Exhibition Swine for Influenza A Virus Using Body Temperature.

Authors:  A S Bowman; J M Nolting; J D Workman; M Cooper; A E Fisher; B Marsh; T Forshey
Journal:  Zoonoses Public Health       Date:  2015-04-17       Impact factor: 2.702

5.  Genetic reassortment of avian, swine, and human influenza A viruses in American pigs.

Authors:  N N Zhou; D A Senne; J S Landgraf; S L Swenson; G Erickson; K Rossow; L Liu; K j Yoon; S Krauss; R G Webster
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Detection of Influenza A virus in porcine oral fluid samples.

Authors:  Susan E Detmer; Devi P Patnayak; Yin Jiang; Marie R Gramer; Sagar M Goyal
Journal:  J Vet Diagn Invest       Date:  2011-03       Impact factor: 1.279

7.  Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.

Authors:  Amy L Vincent; Janice R Ciacci-Zanella; Alessio Lorusso; Philip C Gauger; Eraldo L Zanella; Marcus E Kehrli; Bruce H Janke; Kelly M Lager
Journal:  Vaccine       Date:  2010-02-02       Impact factor: 3.641

8.  Swine influenza virus infections. Transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission.

Authors:  D L Wells; D J Hopfensperger; N H Arden; M W Harmon; J P Davis; M A Tipple; L B Schonberger
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

9.  Molecular evidence for interspecies transmission of H3N2pM/H3N2v influenza A viruses at an Ohio agricultural fair, July 2012.

Authors:  Andrew S Bowman; Srinand Sreevatsan; Mary L Killian; Shannon L Page; Sarah W Nelson; Jacqueline M Nolting; Carol Cardona; Richard D Slemons
Journal:  Emerg Microbes Infect       Date:  2012-10-24       Impact factor: 7.163

10.  Influenza A(H1N1)pdm09 virus among healthy show pigs, United States.

Authors:  Gregory C Gray; Jeffrey B Bender; Carolyn B Bridges; Russell F Daly; Whitney S Krueger; Michael J Male; Gary L Heil; John A Friary; Robin B Derby; Nancy J Cox
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

View more
  4 in total

Review 1.  Noninvasive strategies for surveillance of swine viral diseases: a review.

Authors:  Hanna Turlewicz-Podbielska; Jan Włodarek; Małgorzata Pomorska-Mól
Journal:  J Vet Diagn Invest       Date:  2020-07       Impact factor: 1.279

2.  Influenza A(H3N2) Virus in Swine at Agricultural Fairs and Transmission to Humans, Michigan and Ohio, USA, 2016.

Authors:  Andrew S Bowman; Rasna R Walia; Jacqueline M Nolting; Amy L Vincent; Mary Lea Killian; Michele M Zentkovich; Joshua N Lorbach; Sarah E Lauterbach; Tavis K Anderson; C Todd Davis; Natosha Zanders; Joyce Jones; Yunho Jang; Brian Lynch; Marisela R Rodriguez; Lenee Blanton; Stephen E Lindstrom; David E Wentworth; John Schiltz; James J Averill; Tony Forshey
Journal:  Emerg Infect Dis       Date:  2017-09       Impact factor: 6.883

3.  Influenza A Virus Field Surveillance at a Swine-Human Interface.

Authors:  Benjamin L Rambo-Martin; Matthew W Keller; Malania M Wilson; Jacqueline M Nolting; Tavis K Anderson; Amy L Vincent; Ujwal R Bagal; Yunho Jang; Elizabeth B Neuhaus; C Todd Davis; Andrew S Bowman; David E Wentworth; John R Barnes
Journal:  mSphere       Date:  2020-02-05       Impact factor: 4.389

4.  Shortening Duration of Swine Exhibitions to Reduce Risk for Zoonotic Transmission of Influenza A Virus.

Authors:  Dillon S McBride; Jacqueline M Nolting; Sarah W Nelson; Michele M Spurck; Nola T Bliss; Eben Kenah; Susan C Trock; Andrew S Bowman
Journal:  Emerg Infect Dis       Date:  2022-09-09       Impact factor: 16.126

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.